CAS 2126928-92-3
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 Produkte.
Clindamycin Palmitate Hydrochloride Sulfoxide (7-Chloro-1,6,7,8-tetradeoxy-6-[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido]-1-methylsulfinyl-L-threo-α-D-galacto-octopyranose 2-palmitate hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormel:C34H63ClN2O7S·HClFarbe und Form:White PowderMolekulargewicht:714.38113Clindamycin Palmitate Sulfoxide HCl
CAS:Formel:C34H63ClN2O7S·HClFarbe und Form:White To Off-White SolidMolekulargewicht:679.40 36.46Clindamycin Palmitate Sulfoxide HCl (Mixture of Diastereomers)
CAS:Formel:C34H63ClN2O7S·HClMolekulargewicht:679.40 36.46Clindamycin Palmitate Sulfoxide Hydrochloride (>90%)
CAS:Kontrolliertes Produkt<p>Applications Clindamycin Palmiitate Sulfoxide Hydrochloride, is an impurity in the synthesis of Clindamycin Palmitate Hydrochloride (C580035), a semi-synthetic antibiotic with high bioavailability. Clindamycin Palmitate is an antibacterial.<br>References Bharathi, Ch. et al.: J. Pharm. Biomed. Anal., 48, 1211 (2008); Platzer, D., et al.: J. Pharm. Biomed. Anal., 41, 84 (2006);<br></p>Formel:C34H63ClN2O7S·ClHReinheit:>90%Farbe und Form:NeatMolekulargewicht:715.85Clindamycin 2-palmitate sulfoxide
CAS:<p>Clindamycin 2-palmitate sulfoxide is a semisynthetic antibiotic, which is a derivative of clindamycin. It originates from lincomycin, a natural antibiotic produced by the bacterium *Streptomyces lincolnensis*. This compound functions as a prodrug, which is converted into its active form in the body. Its mode of action involves inhibiting bacterial protein synthesis by binding to the 50S subunit of the ribosome, thereby preventing the growth and replication of susceptible bacteria.</p>Formel:C34H64Cl2N2O7SReinheit:Min. 95%Molekulargewicht:715.9 g/molClindamycin Palmitate Sulfoxide Hydrochloride
CAS:Formel:C34H63ClN2O7SHClMolekulargewicht:679.40 : 36.46
